(Q38071565)

28 August 2017

1 reference

title

Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review (English)

1 reference

28 August 2017

0 references

1 reference

6

1 reference

28 August 2017

7

1 reference

28 August 2017

8

Pablo Alonso-Coello

0 references

Ingrid Arevalo-Rodriguez

object named as

Ingrid Arevalo-Rodriguez

1

0 references

Ignasi Gich

object named as

Ignasi Gich

5

0 references

author name string

Olga L Pedraza

2

1 reference

28 August 2017

Andrea Rodríguez

3

1 reference

28 August 2017

Erick Sánchez

4

1 reference

28 August 2017

Pablo Alonso-Coello

8

1 reference

28 August 2017

language of work or name

English

0 references

publication date

2 January 2013

1 reference

American Journal of Alzheimer's Disease & Other Dementias

28 August 2017

published in

1 reference

28 August 2017

volume

28

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

111-119

1 reference

Global prevalence of dementia: a Delphi consensus study

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

The worldwide societal costs of dementia: Estimates for 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

AGREE II: Advancing guideline development, reporting and evaluation in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Dementia diagnostic guidelines: methodologies, results, and implementation costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis of Alzheimer's disease in Brazil: diagnostic criteria and auxiliary tests. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: 2. Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Recommendations for best practices in the treatment of Alzheimer's disease in managed care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Improving the use of research evidence in guideline development: 4. Managing conflicts of interests

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Sources of bias for authors of clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

The vexing problem of guidelines and conflict of interest: a potential solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512470209

21 January 2018

Identifiers

DOI

10.1177/1533317512470209

1 reference

28 August 2017

1 reference